Viking Global Opportunities Parent GP LLC's Net Worth
$0
Who is Viking Global Opportunities Parent GP LLC?
Viking Global Opportunities Parent GP LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PROCEPT BioRobotics Corp, Amylyx Pharmaceuticals, Inc., RayzeBio, Inc., 4D Molecular Therapeutics, Inc., Roivant Sciences Ltd., BridgeBio Pharma, Inc., Ginkgo Bioworks Holdings, Inc., Rallybio Corp, Frazier Lifesciences Acquisition Corp, Inhibrx, Inc., APi Group Corp, STANDARD BIOTOOLS INC., and Inhibrx Biosciences, Inc..
SEC CIK
Viking Global Opportunities Parent GP LLC's CIK is 0001886738
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Amylyx Pharmaceuticals, Inc. (AMLX) Snapshot price: $2.37
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.26% | -1.40M |
$29.80 | -$41,719,639.31 | 12.24M |
Sep 8 - Sep 9
| |||
Form 4
|
∞
| 7.17M |
$19.00 | $43,700,000.00 | 7.17M |
Jan 11 - Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RayzeBio, Inc. (RYZB) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.64M |
—
|
—
|
0
|
Feb 26
| |||
Form 4
| -100.00% | -6.64M |
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
∞
| 6.64M |
$18.00 |
—
| 6.64M |
Sep 19
| |||
Form 4
|
∞
| 6.64M |
$18.00 |
—
| 6.64M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
4D Molecular Therapeutics, Inc. (FDMT) Snapshot price: $15.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.28% | -540.00K |
$19.53 | -$10,546,200.00 | 4.25M |
Jan 4
| |||
Form 4
| +21.59% | 850K |
$16.00 | $13,600,000.00 | 4.79M |
May 9
| |||
| No matching records found | |||||||||
Roivant Sciences Ltd. (ROIV) Snapshot price: $12.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -14.73% | -13.00M |
$9.90 | -$128,700,000.00 | 75.24M |
Jun 22
| |||
| No matching records found | |||||||||
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $30.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.63% | -1.50M |
$35.00 | -$52,500,000.00 | 25.12M |
Jul 18
| |||
| No matching records found | |||||||||